Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 3744

1.

Validation of the Vaccination Confidence Scale: A Brief Measure to Identify Parents at Risk for Refusing Adolescent Vaccines.

Gilkey MB, Reiter PL, Magnus BE, McRee AL, Dempsey AF, Brewer NT.

Acad Pediatr. 2015 Aug 20. pii: S1876-2859(15)00215-6. doi: 10.1016/j.acap.2015.06.007. [Epub ahead of print]

PMID:
26300368
2.

An update on barriers to adolescent human papillomavirus vaccination in the USA.

Berenson AB.

Expert Rev Vaccines. 2015 Aug 21:1-8. [Epub ahead of print]

PMID:
26292763
3.

Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008-2012.

Hariri S, Markowitz LE, Bennett NM, Niccolai LM, Schafer S, Bloch K, Park IU, Scahill MW, Julian P, Abdullah N, Levine D, Whitney E, Unger ER, Steinau M, Bauer HM, Meek J, Hadler J, Sosa L, Powell SE, Johnson ML, Group HI.

Emerg Infect Dis. 2015 Sep;21(9):1557-61. doi: 10.3201/eid2109.141841.

4.

Committee Opinion No. 641: Human Papillomavirus Vaccination.

[No authors listed]

Obstet Gynecol. 2015 Sep;126(3):e38-43. doi: 10.1097/01.AOG.0000471170.79174.84.

PMID:
26287792
5.

Committee Opinion Summary No. 641: Human Papillomavirus Vaccination.

[No authors listed]

Obstet Gynecol. 2015 Sep;126(3):693. doi: 10.1097/01.AOG.0000471169.97100.9d.

PMID:
26287785
6.

Impact of Gender-Specific Human Papillomavirus Vaccine Recommendations on Uptake of Other Adolescent Vaccines: Analysis of the NIS-Teen (2008-2012).

Bednarczyk RA, Orenstein WA, Omer SB.

J Public Health Manag Pract. 2015 Aug 14. [Epub ahead of print]

PMID:
26280380
7.

An update on barriers to adolescent human papillomavirus vaccination in the USA.

Berenson AB.

Expert Rev Vaccines. 2015 Aug 13:1-8. [Epub ahead of print]

PMID:
26272483
8.

Reduced dose human papillomavirus vaccination: An update of the current state-of-the-art.

Toh ZQ, Licciardi PV, Fong J, Garland SM, Tabrizi SN, Russell FM, Mulholland EK.

Vaccine. 2015 Aug 10. pii: S0264-410X(15)01106-8. doi: 10.1016/j.vaccine.2015.07.102. [Epub ahead of print] Review.

PMID:
26271829
9.

Knowledge on HPV Vaccine and Cervical Cancer Facilitates Vaccine Acceptability among School Teachers in Kitui County, Kenya.

Masika MM, Ogembo JG, Chabeda SV, Wamai RG, Mugo N.

PLoS One. 2015 Aug 12;10(8):e0135563. doi: 10.1371/journal.pone.0135563. eCollection 2015.

10.

Human papillomavirus and oral cancer: a primer for dental public health professionals.

Chattopadhyay A, Weatherspoon D, Pinto A.

Community Dent Health. 2015 Jun;32(2):117-28. Review.

PMID:
26263606
11.

Current status of human papillomavirus vaccination.

Brotherton JM, Ogilvie GS.

Curr Opin Oncol. 2015 Sep;27(5):399-404. doi: 10.1097/CCO.0000000000000211.

PMID:
26258273
12.

Plant-produced viral bovine vaccines: what happened during the last 10 years?

Ruiz V, Mozgovoj MV, Dus Santos MJ, Wigdorovitz A.

Plant Biotechnol J. 2015 Aug 6. doi: 10.1111/pbi.12440. [Epub ahead of print]

PMID:
26250843
13.

Coadministration of a 9-Valent Human Papillomavirus Vaccine With Meningococcal and Tdap Vaccines.

Schilling A, Parra MM, Gutierrez M, Restrepo J, Ucros S, Herrera T, Engel E, Huicho L, Shew M, Maansson R, Caldwell N, Luxembourg A, Ter Meulen AS.

Pediatrics. 2015 Aug 3. pii: peds.2014-4199. [Epub ahead of print]

PMID:
26240207
14.

Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus.

Kash N, Lee MA, Kollipara R, Downing C, Guidry J, Tyring SK.

J Clin Med. 2015 Apr 3;4(4):614-33. doi: 10.3390/jcm4040614. Review.

15.

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2014.

Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans LD, Singleton JA, Curtis CR, MacNeil J, Markowitz LE, Stokley S.

MMWR Morb Mortal Wkly Rep. 2015 Jul 31;64(29):784-92.

16.

Parent HPV vaccine perspectives and the likelihood of HPV vaccination of adolescent males.

Clark SJ, Cowan AE, Filipp SL, Fisher AM, Stokley S.

Hum Vaccin Immunother. 2015 Jul 30:0. [Epub ahead of print]

PMID:
26225463
17.

Vaccination of adolescents with chronic medical conditions: Special considerations and strategies for enhancing uptake.

Hofstetter AM, LaRussa P, Rosenthal SL.

Hum Vaccin Immunother. 2015 Jul 25:0. [Epub ahead of print]

PMID:
26212313
18.

Attitudes and Perceptions of the Human Papillomavirus Vaccine in Caribbean and African American Adolescent boys and Their Parents.

Shao SJ, Nurse C, Michel L, Joseph MA, Suss AL.

J Pediatr Adolesc Gynecol. 2015 Oct;28(5):373-7. doi: 10.1016/j.jpag.2014.11.003. Epub 2014 Dec 9.

PMID:
26209867
19.

Risk of spontaneous abortion and other pregnancy outcomes in 15-25 year old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom.

Baril L, Rosillon D, Willame C, Angelo MG, Zima J, van den Bosch JH, Van Staa T, Boggon R, Bunge EM, Hernandez-Diaz S, Chambers CD.

Vaccine. 2015 Jul 20. pii: S0264-410X(15)00968-8. doi: 10.1016/j.vaccine.2015.07.024. [Epub ahead of print]

20.

Prevalence of type-specific HPV among female university students from northern Brazil.

Vieira RC, Monteiro Jdo S, Manso EP, Dos Santos MR, Tsutsumi MY, Ishikawa EA, Ferrari SF, Lima KV, de Sousa MS.

Infect Agent Cancer. 2015 Jul 22;10:21. doi: 10.1186/s13027-015-0017-x. eCollection 2015.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk